Statement of Steven F. Molo on Fourth Amended NCAA Settlement
Amended settlement fails to correct harm to student athletes
NEW YORK, May 8, 2025 /PRNewswire-PRWeb/ -- Statement of Steven F. Molo, counsel for the Menke-Wiedenbach Objectors, upon the filing of the Fourth Amended Settlement in In re College Athlete NIL Litigation to modify the settlement to address the roster limit objection:
"While the NCAA and Class Counsel have acknowledged our objection to roster caps is valid, their proposed mushy modification doesn't go far enough. Many, many student athletes have had something taken away from them. The fight will continue."
About MoloLamken
MoloLamken handles complex business disputes, IP disputes, and white collar defense and investigations in trial and appellate courts, including the Supreme Court of the United States, as well as arbitral forums. Our clients include leading corporations, hedge funds, private equity firms, investors, inventors, executives, and foreign sovereigns. With offices in New York, Chicago, and Washington, D.C., we're engaged in some of the most significant disputes and investigations in the United States today.
"Brilliant lawyers with courtroom savvy" — Benchmark Litigation.
For more information, visit www.mololamken.com.
Follow us on LinkedIn at https://www.linkedin.com/company/mololamken-llp.
Media Contact
Tobias Wertime, MoloLamken LLP, 1 (212) 230-5908, [email protected], https://www.mololamken.com/
View original content:https://www.prweb.com/releases/statement-of-steven-f-molo-on-fourth-amended-ncaa-settlement-302449597.html
SOURCE MoloLamken LLP
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Why Visual Asset Repurposing Is Becoming a Competitive Advantage
- Simple Expands Retail POS Nationwide With 22+ Modules at $99 Per Month
- Buddy Brings Native Ecommerce to Flowhub Dispensaries, Live in 24 Hours
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Hedge FundsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share